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Adults with congenital heart disease (ACHD) face noncardiac healthcare challenges as the population ages. We assessed whether
women with ACHD have comparable cancer screening rates to non-ACHD women in a cardiac practice and to the general
population. We performed a retrospective review of 175 adult women seen in a cardiac care center in 2009–2011. Data on Pap tests,
mammography,andcolonoscopies,werecollectedthroughelectronicmedicalrecordsandprimarycareproviderrecords.Adequate
documentation was available for 100 individuals with ACHD and 40 comparator cardiac patients. The adequacy of screening was
determinedusingguidelinessetforthbytheAmericanCancerSocietyin2010.Comparedwiththenationalaverage,ACHDpatients
had significantly lower rates of Pap tests (60% versus 83%, 𝑃 < 0.001) and mammography (48% versus 72%, 𝑃 < 0.001). Compared
with non-ACHD women in the same practice, ACHD patients had consistently lower rates of mammography (48% versus 81%,
𝑃 = 0.02) and colonoscopies (54% versus 82%, 𝑃 = 0.23). As the population of ACHD individuals ages, attention to cancer
screening becomes increasingly important but may be overlooked in this population. Primary care physicians and cardiologists
should collaborate to ensure appropriate cancer screening for this growing population.
1. Background
A sar e s u l to fs u r g i c a la d v a n c e sa sw e l la si m p r o v e m e n t s
in diagnosis and medical management, there may now be
over 1 million adults with congenital heart disease in the
United States, and this population is rapidly expanding
[1]. As this population ages, the annual incidence of age-
related malignancy rises, and caregivers must now ensure
adequateandtimelypreventivecancerscreeningfortheadult
congenital heart disease (ACHD) patient.
Primary care of the ACHD patient may be overshadowed
by late cardiac complications including arrhythmia, valvular
disease, andheart failure[2,3]. The European Society of Car-
diologyand2008AmericanCollegeofCardiology/American
Heart Association guidelines have both called for increased
access to primary care physicians and attention to health
maintenance [4, 5].
To develop strategies to improve overall screening, it is
essential to identify groups of individuals with inadequate
screening rates and to assess potential barriers to preven-
tive screening. Known risk factors for poor participation
in preventive screening include low socioeconomic status,
lower levels of education, immigrant status, lack of health
insurance and importantly, lack of a primary care provider
[6]. Individuals with chronic disease rely on subspecialists
for their medical care and may not have a primary care
physician or gynecologist thus reducing the likelihood of
access to general preventive care [7, 8]. Even among chronic
disease patients who regularly follow up with primary care
providers there appears to be an overall reduction in par-
ticipation with preventive care [9, 10]. ACHD patients may
haveadditionaluniquebarrierstoadequatecancerscreening.
They are frequently lost to followup during adolescence and
early adulthood, for several reasons, including inadequate2 ISRN Cardiology
understanding by patients and parents of the importance of
life-long medical care [11] and challenges to transition from
adolescent to adult care [12, 13].
In this study, we investigate the documentation of pre-
ventive cancer screening provided to women with congenital
heart disease. We hope to raise awareness among cardiolo-
gistsandprimarycarephysiciansalikeregardingtheessential
need for preventive screening for treatable diseases in this
growing and aging ACHD patient population.
2. Methods
This retrospective institutional review board approved study
of women over 18 years of age was performed at a single
ACHD center. Primary care for these individuals was pro-
videdbyseveralprimarycarepracticesincludingcommunity
centers, multispecialty practices, and academic centers. One
h u n d r e ds e v e n t yfi v ep a t i e n t sw i t hA C H Ds e e ni nt h ec a r d i -
ology practice were consecutively selected between 2009 and
2011. Individuals with isolated patent foramen ovale, mitral
valveprolapse,orisolatedbicuspidaorticvalvewereexcluded
from the ACHD cohort. One hundred ACHD patients had
adequate medical record data for analysis. Data regarding
medicalhistory,sexualhistory,papsmears,colonoscopy,and
mammography were obtained from patient medical records,
either from the electronic medical record or from primary
care physicians’ faxed documentation.
Adequacy of screening was determined using criteria
set forth by the American Cancer Society (ACS) in 2010
(Table 1)[ 14]. While there is consensus among organizations
regarding the intervals for cervical screening [14, 15]a n d
colonoscopy [14, 16], there has been controversy regarding
the recommended mammography interval. Although the US
Preventive Services Task Force guidelines call for mammog-
r a p h ye v e r y2y e a r sa ft e ra g e5 0[ 17], many groups including
ACS, American College of Gynecologists, and American
College of Radiology/Society of Breast Imaging continue to
recommend annual mammography after age 40 years [14, 18,
19], the criteria which were applied in our current analysis.
Forty individuals with simple noncongenital cardiac dis-
ease (Figure 1(a)) seen in the same practice and age matched
to within 3 years were consecutively selected as a compara-
t o rp o p u l a t i o n .Th ec o n g e n i t a lh e a r td i s e a s es t u d yg r o u p ’ s
screening rates were also compared to the Healthy People
2010 targets [21], ten-year national objectives established by
the US Department of Health and Human Services to be
achieved by 2010, contemporary to this study, and to US
population screening rates determined by the Centers for
D i s e a s eC o n t r o la n dP r e v e n t i o ni n2 0 1 0[ 22].
Statistical analysis was performed using EpiCalc 2000
(Brixton Health) [23]. Continuous variables were assessed
using the student’s t-test. Categorical variables were assessed
wi thth eCh i - sq ua r et e s t .S i gn i fi ca n c ew a sm ea s u r eda tal ev e l
of 𝑃 < 0.05.
Table 1: Guidelines and criteria for determining cancer screening
adequacy.
Age of eligibility Screening adequate if
No. tests obtained Within (yrs)
∗
Pap 21 2 𝑇−3
Mammography 40 2 𝑇−2
Colonoscopy 50 1 𝑇−1 0
∗𝑇istheyearofenrolmentorage70,75,and75forPaptests,mammograms,
and colonoscopies, respectively. Screening was deemed adequate if at least
no. tests were obtained in a specified time interval prior to enrolment [14].
Table 2: Baseline Demographics.
ACHD
(𝑛 = 100)
Control
(𝑛=4 0 ) Total
Median age in years (SD) 38 (14) 42 (15) 𝑃 value
0.2NS
18–40 59 19 78
41–50 20 11 31
51–64 14 6 20
>65 74 1 1
Race
White 89 33 122
African American 13 4
Asian 42 6
American Indian 00 0
Native Hawaiian/Pacific Islander 00 0
Hispanic 61 7
More than one race or other 00 0
No data 01 1
3. Results
3.1. Baseline Demographics. Individuals with ACHD had a
median age of 38 years (SD 14) (Table 2), with 33% simple,
53%moderate,14%complexdiseaseseveritypertheBethesda
classification [20]( Figure 1(b)). They demonstrated variable
severity based on New York Heart Association (NYHA) class
(Figure 1(c)). The majorityof individuals identified their race
as Caucasian. There was a broad range of congenital heart
lesions encompassed by this population (Figure 1(b)).
3.2. Breast Cancer Screening. Breast cancer screening rates
were significantly lower in the ACHD population when com-
pared with the US national screening rate as well as the local
comparator population (Table 3; Figure 2). Mammography
was performed in only 48% of the ACHD group compared
to 81% of the non-ACHD cardiac group (𝑃 = 0.02)a n d7 2 %
of the US population in 2010 (𝑃 < 0.001). The ACHD group
fell short of the national mammography target of 70%.
3.3. Cervical Cancer Screening. Adequate cervical cancer
screening was seen in 60% of both ACHD and comparator
groups, compared with 83% of the US population in 2010ISRN Cardiology 3
Arrhythmia
17%
Valve disease
22%
Cardiac 
symptoms
33%
Cardiovascular 
risk factors
28%
(a)
Moderate (53): 
Coarctation of the aorta (14) 
Tetralogy of fallot (13) 
Pulmonic/RVOT stenosis (5)
AVSD, cleft mitral valve (4)
TAPVR or PAPVR (4)
Complex VSD (3)
Ebstein anomaly (3)
Subaortic membrane (2) 
ALCAPA (2)
DCRV (1)
PDA (1)
Sinus venosus (1)
Simple (33): 
ASD, VSD (26)
Pulmonic stenosis (3)
Mitral regurgitation (3)
Unicuspid aortic valve (1) 
Complex (14):
TGA (6)
Eisenmenger  (3)
Tricuspid atresia (3)
Common ventricle (1) 
Pulmonary atresia (1)
Complex
14%
Simple
33%
Moderate
53%
(b)
I
52%
II
30%
III
12%
IV
6%
(c)
Figure1:(a)Thecontrolgroupcontained40womenwithoutcongenitalheartdiseasewhopresentedwithcardiacsymptomssuchaschestpain
or palpitations, cardiovascular risk factors, valvular disease, or arrhythmia. (b) The study group contained 100 women with congenital heart
diseasewhoselesionsspannedthespectrumoftheBethesdaclassification[20]withsimple,moderate,andcomplexlesionsallrepresented.(c)
UsingtheNewYorkHeartAssociationFunctionalClassification,mostwomeninthestudygrouphadeithernolimitationinordinaryphysical
activity (Class I) or mild symptoms (Class II). Fewer subjects had marked limitation in activity due to symptoms (Class III) or symptoms at
rest (Class IV).
Table 3: Screening rates in adult congenital heart disease group versus control group versus 2010 US population screening rates.
Test ACHD (𝑛 = 100)A C H DC o n t r o l ( 𝑛=4 0 )C o n t r o l𝑃 value US Pop US Pop ∗𝑃 value
No. eligible Screening rate No. eligible Screening rate No. eligible screening rate [22]
Pap 94 60% 35 60% 0.87 8999 83% <0.001
Mammogram 44 48% 21 81% 0.02 4869 72% <0.001
Colonoscopy 24 54% 11 82% 0.23 8914 59% 0.82
∗𝑃 value for ACHD compared with US population screening rate.
(𝑃 < 0.001). The national target for cervical cancer screening
was 90%, with all three populations falling short of the target
screening rate.
3.4. Colon Cancer Screening. Adequate colon cancer screen-
ing was performed in 54% of the ACHD population versus
81% of comparator group (𝑃 = 0.23), with a national
screening rate of 58% (𝑃-value for ACHD versus national
population0.82).Thenationaltargetforcoloncancerscreen-
ing was 50%, with all three populations achieving the target
screening rate.
3.5. ACHD Disease Severity and Screening Rates. Individuals
with simple, moderate, and complex disease had 58%, 37%,
and 44% adequate overall screening, respectively. Adequacy
of screening decreased as cardiac symptoms increased based
onNYHAclass(50%NYHAClassI,47%NYHAClassII,25%
NYHA Class III, 17% NYHA Class IV; 𝑃=0 . 2 )( Table 4).
3.6. Screening Results and Followup. All ACHD and cardiac
control group subjects had a primary care physician. There
wasdocumentationoffollowupforallabnormalresultsinthe
study population (Table 5).4 ISRN Cardiology
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Figure 2: These bar graphs compare the study group’s screening
rates for cervical cancer (𝑛=9 4 ), breast cancer (𝑛=4 4 ), and colon
cancer(𝑛=2 4 )withthoseoftheUSpopulation[22]andtheHealthy
People 2010 target screening rates [21].
Table 4: Screening rates by New York Heart Association class.
No. ACHD patients in
class
(𝑛 = 100)
% adequately screened
(𝑃 = 0.22)
I 52 50%
II 30 47%
III 12 25%
IV 61 7 %
4. Discussion
The ACHD population continues to increase in the US,
and both adult and pediatric cardiology practices as well
as primary care providers are seeing an influx of these
individuals. As the population ages, the incidence of cancer
will rise in this population as well. Our study is the first to
examine the rates of cancer screening documented among
ACHD patients.
The overall screening rate for breast, cervical, and colon
cancer was 45% in the ACHD population, with a failure to
achieve target screening goals or meet the national screening
averages in breast cancer and cervical cancer screening.
Colon cancer screening rates for the ACHD population were
s i m i l a rt ot h en a t i o n a la v e r a g ea n ds u r p a s s e dt h eH e a l t h y
People 2010 target. Colonoscopy rates in the local cardiac
patient control group were higher, though not statistically
significant. This may be due to the control group’s compo-
sition of overall healthier individuals with arrhythmia, mild
valvulardisease,fewercardiacsymptoms,andcardiovascular
risk factors, reflecting a proactive patient population.
Barriers to adequate cancer screening in this population
are likely multifactorial and include both patient and physi-
cian factors. Patients with chronic disease and survivors of
potentially life-threatening conditions may place less value
on screening and preventive treatment [10, 24]p o s s i b l y
T a b l e5 :F o l l o w u po fa b n o r m a lr e s u l t s .
ACHD (𝑛 = 100)C o n t r o l ( 𝑛=4 0 )
No.
abnormal
Rate of
followup
No.
abnormal
Rate of
followup
Paps 12 83.33% 2 100%
Mammograms 31 0 0 %3100%
Colonoscopies 10 70% 3 100%
contributing to lower cancer screening rates. The significant
discrepancyinbreastcancerscreeningmaystemfromACHD
patient hesitancy to undergo mammography. Perceived pro-
cedural discomfort in individuals with a prior sternotomy,
potentialadditionalradiationexposureafterrepeatedcardiac
imaging, and body image issues have all been anecdotally
cited. If ACHD survivors rely primarily on cardiologists for
routinemedicalcare,theymayfailtoreceivecancerscreening
services.
Individuals with worse functional status (higher NYHA
Class) had lower rates of cancer screening. As the severity of
an individual’s disease increases, competing medical comor-
bidities, patient hesitation to undergo additional testing, or
physician choice to forego testing in patients with limited life
expectancy may influence screening compliance rates.
5. Study Limitations
The limitations of this study are those common to retrospec-
tive medical record based analyses including a dependence
on clinical detail provided and a lack of information about
patient preferences or provider decision making. Socioe-
conomic characteristics were not robust in this database.
The overall rate of cervical cancer screening is low in both
groups, and it is possible that some patients may have a local
gynecologist,andthosePaptestsmaynothavebeencaptured
in our database. Additionally, our analysis is limited because
the overall number of patients eligible for colonoscopy is
low. Conversely, the individuals studied were drawn from a
population that attended cardiology clinic and have access to
primary care. This may lead to overestimation of screening
compliance rates, as many ACHD individuals nationwideare
lost to followup and do not have primary care physicians and
are therefore less likely to undergo cancer screening.
6. Conclusions
As the population of individuals with ACHD continues to
grow and age, screening for preventable disease becomes an
important responsibility of their care providers. The national
targets for cancer screening rates continue to rise. The
HealthyPeople2020targetforbreastcancerscreeningis81%,
cervical cancer screening is 93%, and colon cancer screening
is 70% [25]. To meet these goals, cardiac providers and
primary care physicians must define their roles in long-term
management of ACHD patients. Patient education regarding
the importance of health maintenance and cancer screeningISRN Cardiology 5
should be a priority for providers and patient advocacy
groups.
Overthepast40years,eachdecadehasbroughtadvances
in medical care and quality of life to adults with congenital
heart disease. ACHD caregivers and patients have redirected
conversations from exercise restriction to exercise encour-
agement and have recognized that contraception and family
planning are essential discussions, and we now, as a com-
munity, face the challenge of addressing noncardiac issues
associated with increased life expectancy. Promoting cancer
screening may not only save lives, it is the next opportunity
to transform our approach to the ACHD population’s overall
care.
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